Lots of Biogenesis news has come out in the past few minutes. We have news of three new names in the Biogenesis scandal, a couple being cleared as well as more news of players agreeing not to appeal and to serve their suspensions.
The new names: The Mets’ Jordany Valdespin, the Phillies’ Antonio Bastardo and the Astros’ Sergio Escalona are all going to receive 50-game suspensions.
According to multiple reports, in addition to Nelson Cruz, Jhonny Peralta, Everth Cabrera, Francisco Cervelli, Jesus Montero, Cesar Puello, Fautino De Los Santos, Fernando Martinez and Jordan Norberto have all accepted 50-game suspensions. That’s 12 players plus Ryan Braun and Alex Rodriguez.
Cleared, either completely or in terms of new discipline: Bartolo Colon, Yasmani Grandal, and Melky Cabrera, all who will get no additional discipline over what they have already served (each received 50-game suspensions last season). Finally, there have been no violations found for Gio Gonzalez of the Nationals or Danny Valencia of the Orioles. Each were named in the original Miami New Times report about Biogenesis, but there was not much in the way of evidence against them in the actual Biogenesis documents.
Barring any new surprises, this should be the extent of the suspended players. And barring any last minute settlement between A-Rod and Major League Baseball, Rodriguez now stands alone as the sole player mounting an appeal.
The Cubs soundly defeated the Cardinals on Monday night, 10-2, sending their magic number down to one. They will try to clinch the NL Central on Tuesday with another win against the Cardinals. Alternatively, if they lose, they can still clinch if the Brewers also lose on Tuesday.
The Cubs, of course, won the Central last year en route to winning their first World Series since 1908. It wasn’t nearly as easy this year as the club was below .500 entering June and was exactly at .500 entering July. A 16-8 July, 17-12 August, and 15-8 September have helped put the Cubs back in position to return to the postseason.
Not to be forgotten, the Cardinals were eliminated from NL Central contention with Monday’s loss. Now they have their sights set on the second NL Wild Card slot and currently trail the Rockies in that race.
The matchups for Tuesday’s action:
Dennis Lin of the San Diego Union Tribune reports that Padres pitcher Carter Capps will undergo surgery this offseason to address thoracic outlet syndrome, which doctors believe caused the right-hander’s blood clots. The Padres hope to have him ready by spring training next year.
Capps, 27, underwent Tommy John surgery last year and didn’t debut this season until August 7. He made 11 relief appearances, yielding nine runs on 12 hits and two walks with seven strikeouts in 12 1/3 innings. He went back on the DL on September 12 due to the blood clot issue.
The Padres acquired Capps from the Marlins last July in the Andrew Cashner trade which ended up having a lot of moving parts. Capps will enter his third and final year of arbitration eligibility this offseason. It’s quite possible the Padres choose to non-tender him.